Ionis has committed to a phase 3 programme for its antisense therapy for rare genetic disorder Angelman syndrome, just weeks after Biogen decided against exercising an option to license the drug.

A disabled man is ‘powerless’ to oppose a ‘traumatising eviction’ from his care home of ten years due to a funding refusal ...

Several companies are working on new investigational treatments for Angelman syndrome, a rare genetic disorder that affects the nervous system and causes developmental delays, intellectual disability, ...

After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers ...

Huntington's disease is a rare genetic, autosomal dominant, neurodegenerative disease, caused by CAG repeat expansions in the HTT gene, that is polymorphic on the healthy allele and contains more than ...

Targets to improve dementia diagnoses and boost women's health have been dropped from NHS planning guidance. And controversies, such as physician associates (PAs) – 'cut-price medics' with only ...

Several conditions can cause symptoms that resemble ADHD, including mood disorders, diabetes, or hearing problems. An accurate diagnosis from a mental health professional is key to ensuring proper ...

A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, ...

Join us for Purple Day ® on March 26 to harness the Power In Purple, the Epilepsy Foundation’s 2025 theme emphasizing the strength and resilience of the epilepsy community. Together, we can turn ...